Prosecution Insights
Prosecution Insights
Tech Center 4100 • Art Units: 1645 3763 3783 4100
This examiner grants 74% of resolved cases
Hamza A. Darb is an examiner in Tech Center 4100, specifically within Art Unit 1645. He has 544 resolved cases and an allowance rate of 74.4%. This rate indicates a favorable environment for applicants. The interview lift is 30.9%, which is a significant figure showing that interviews are a very effective tool for securing an allowance.
The median days to allowance for this examiner is 1225. This timeline suggests a prosecution cycle of over three years. For practitioners, the 544 resolved cases offer a reliable data set for strategy. The 74.4% allowance rate and the 30.9% interview lift suggest that direct engagement is a key part of a successful prosecution strategy. In Art Unit 1645, the 1225-day median pendency is an important benchmark for managing client expectations and planning for a multi-year process.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18283685 | PERILESIONAL TREATMENT OF SKIN CONDITIONS | Final Rejection | Veradermics Incorporated |
| 18647821 | CATHETER INCLUDING AN ELONGATED BODY WITH INTERCONNECTING STRUTS | Non-Final OA | Covidien LP |
| 18721433 | FLUOROSCOPIC IMAGE GUIDED ROBOTIC BLOOD VESSEL CANNULATION | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18720705 | AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY | Non-Final OA | Bayer HealthCare LLC |
| 17433795 | MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | Non-Final OA | ELI LILLY AND COMPANY |
| 19364715 | CATHETER CONSTRUCTION | Non-Final OA | Maduro Discovery, LLC |
| 17055447 | THERAPY-BASED DATABASE MODEL FOR GENERATING DRUG LIBRARIES | Final Rejection | Fresenius Vial SAS |
| 17972462 | METHOD OF FORMING A BALLOON | Non-Final OA | Medtronic, Inc. |
| 18611540 | SECURE INPUT ON A CONTROL COMPONENT FOR A DIALYSIS MACHINE | Non-Final OA | Fresenius Medical Care Deutschland GmbH |
| 18660303 | MICRONEEDLE PATCH AND METHOD OF FABRICATION THEREOF | Non-Final OA | City University of Hong Kong |
| 18110086 | Vascular Access System with Flow Restriction Device | Non-Final OA | Becton, Dickinson and Company |
| 18075220 | INTRODUCER NEEDLE HAVING A FLASHBACK NOTCH AND RELATED DEVICES | Non-Final OA | Becton, Dickinson and Company |
| 17968244 | Medical Device Hub and System for Securing a First Medical Device Relative to a Second Medical Device | Final Rejection | Becton, Dickinson and Company |
| 17917222 | Steerable Cannulas and Hinged or Steerable Needles Including Access Sets and Methods Thereof | Non-Final OA | Becton, Dickinson and Company |
| 16725079 | ACTIVATING MECHANISM FOR A MEDICAMENT DELIVERY DEVICE AND MEDICAMENT DELIVERY DEVICE | Final Rejection | Sanofi |
| 18474839 | ZERO GAP AUTOMATED INSULIN DELIVERY TREATMENT SYSTEM | Non-Final OA | Tandem Diabetes Care, Inc. |
| 17809668 | GUIDE EXTENSION CATHETERS | Final Rejection | Cardiovascular Systems, Inc. |
| 18706823 | Sub-assembly for a medicament delivery device | Non-Final OA | SHL Medical AG |
| 17851889 | SYSTEM AND METHOD FOR RESISTANCE-DEPENDENT, SELF-REGULATED MEDICAL PENETRATION | Non-Final OA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 18693219 | Syringe Assembly with In-Molded RFID Sleeve | Non-Final OA | Becton Dickinson France |
| 18031395 | End-of-Dose Indicator for Medical Injection Device | Non-Final OA | Becton Dickinson France |
| 18289542 | Low Profile, Injectable Subcutaneous Vascular Access System and Method | Final Rejection | Bard Peripheral Vascular, Inc. |
| 17793285 | Tool to Enable Catheter Insertion into a Mating Component | Final Rejection | Bard Peripheral Vascular, Inc. |
| 18707797 | PERITONEAL DIALYSIS THERAPY ADJUSTMENT BASED ON FLUID AND CALORIC INTAKE | Non-Final OA | BAXTER HEALTHCARE SA |
| 18666763 | RESERVOIR ASSEMBLY AND DRUG SOLUTION INJECTION DEVICE COMPRISING SAME | Non-Final OA | EOFLOW CO, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy